GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IMS Health Holdings Inc (NYSE:IMS) » Definitions » 3-Year RORE %

IMS Health Holdings (IMS Health Holdings) 3-Year RORE % : 0.00% (As of Jun. 2016)


View and export this data going back to 2014. Start your Free Trial

What is IMS Health Holdings 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. IMS Health Holdings's 3-Year RORE % for the quarter that ended in Jun. 2016 was 0.00%.

The industry rank for IMS Health Holdings's 3-Year RORE % or its related term are showing as below:

IMS's 3-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.54
* Ranked among companies with meaningful 3-Year RORE % only.

IMS Health Holdings 3-Year RORE % Historical Data

The historical data trend for IMS Health Holdings's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMS Health Holdings 3-Year RORE % Chart

IMS Health Holdings Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
3-Year RORE %
Get a 7-Day Free Trial - - - - -

IMS Health Holdings Quarterly Data
Dec10 Dec11 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IMS Health Holdings's 3-Year RORE %

For the Health Information Services subindustry, IMS Health Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMS Health Holdings's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMS Health Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where IMS Health Holdings's 3-Year RORE % falls into.



IMS Health Holdings 3-Year RORE % Calculation

IMS Health Holdings's 3-Year RORE % for the quarter that ended in Jun. 2016 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.42--0.45 )/( 1.15-0 )
=0.87/1.15
=75.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2016 and 3-year before.


IMS Health Holdings  (NYSE:IMS) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


IMS Health Holdings 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of IMS Health Holdings's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


IMS Health Holdings (IMS Health Holdings) Business Description

Traded in Other Exchanges
N/A
Address
IMS Health Holdings Inc was formed on October 23, 2009 in Delaware. The Company is an information and technology services company. It provides clients in the healthcare industry with comprehensive solutions to measure and improve their performance. It has collections of healthcare information, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. The Company provides service to healthcare organizations and decision makers around the world, spanning the breadth of life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company offers various information offerings developed to meet its clients' needs by using data secured from network of suppliers. The Company's offerings compete with various firms, including Accenture, Cognizant Technology Solutions, Covance, Deloitte, Evidera, GfK, Health Market Science, IBM, Infosys, inVentiv Health, Kantar Health, McKinsey, Nielsen, OptumInsight, Parexel, Press Ganey, Quintiles, RTI Health Solutions, Symphony Health Solutions, Synovate Healthcare, The Advisory Board, Trizetto, Verisk and ZS Associates. The Company has trademarks and service marks that it uses in connection with the operation of its business, including IMS Health, IMS, the IMS logo, IMS One, MIDAS, Xponent, DDD, AppScript, AppNucleus, MD360 Provider Performance Management and Evidence360.
Executives
Michael R Mcdonnell officer: EVP and CFO C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
David Bonderman other: Former 10% Owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Lgp Associates V Llc director 11111 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Peridot Coinvest Manager Llc director 11111 SANTA MONICA BOULEVARD, LOS ANGELES CA 90025
Green V Holdings, Llc director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Green Equity Investors V, L.p. director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Green Equity Investors Side V, L.p. director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Gei Capital V, Llc director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Sharad Mansukani director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Lgp Management Inc director 11111 SANTA MONICA BLVD, STE 2000, LOS ANGELES CA 90025
Leonard Green & Partners, L.p. director 11111 SANTA MONICA BLVD, STE 2000, LOS ANGELES CA 90025
Jim Fasano director 83 WOOSTER HEIGHTS, DANBURY CT 06810
Cpp Investment Board Private Holdings, Inc. 10 percent owner ONE QUEEN STREET EAST,, SUITE 2500, TORONTO A6 M5C 2W5
Canada Pension Plan Investment Board 10 percent owner ONE QUEEN STREET EAST, STE 2500, TORONTO ONTARIO A6 0000
Kevin C Knightly officer: SVP, Information Offerings 1499 POST ROAD, FAIRFIELD CT 06824

IMS Health Holdings (IMS Health Holdings) Headlines

From GuruFocus

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016